Home > Forest Laboratories Salary

Forest Laboratories Salary

  • 94
  • 21
  • 75
Low
51,979
Average
103,941
Median
103,417
High
215,000
Total 46 Forest Laboratories Salaries. Sorted by Date, page 3
Ranked By:
Job Title Salaries City Year More info
Senior Development Analyst 110,000-110,000 Commack, NY, 11725 2012 Forest Laboratories Senior Development Analyst Salaries (1)
Forest Laboratories Commack, NY Salaries
Senior Principal Scientist 134,997-134,997 Jersey City, NJ, 07097 2012 Forest Laboratories Senior Principal Scientist Salaries (1)
Forest Laboratories Jersey City, NJ Salaries
Senior Standards Analyst 95,000-95,000 Jersey City, NJ, 07097 2012 Forest Laboratories Senior Standards Analyst Salaries (1)
Forest Laboratories Jersey City, NJ Salaries
Sr. Standards Analyst 94,900-94,900 Jersey City, NJ, 07097 2012 Forest Laboratories Sr. Standards Analyst Salaries (1)
Forest Laboratories Jersey City, NJ Salaries
Technical Application Services Analyst 80,000-80,000 Jersey City, NJ, 07097 2012 Forest Laboratories Technical Application Services Analyst Salaries (1)
Forest Laboratories Jersey City, NJ Salaries
Web Programmer 99,938-99,938 Commack, NY, 11725 2012 Forest Laboratories Web Programmer Salaries (1)
Forest Laboratories Commack, NY Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Forest Laboratories Jobs
See more Forest Laboratories Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
780

All Patents

142

Grant Patents

569

Patents Pending

174

Patents Families

More Recent
Forest Laboratories... Information
  • Forest Laboratories, Inc.
  • Industry: BioTech/Drugs
  • City: New York, NY
  • Forest Laboratories develops, manufactures and markets pharmaceutical products principally in the United States and Europe. Forest's primary therapeutic markets include central nervous system disorders, hypertension and pulmonary disorders. Forest is currently developing additional compounds in these areas as well as in pain management and gastrointestinal disorders. Forest's principal products include Lexapro?, a selective serotonin reuptake inhibitor (SSRI) for the treatment of depression; Celexa?, also for depression; Benicar?,* an angiotensin receptor blocker (ARB) for the treatment of hypertension; and Aerobid?, a metered dose inhaler for treating asthma.